21 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
3 Apr 23
Legend Biotech 6-K
4:01pm
, and as an Advisor at M28. He is Chair Emeritus of the Biotechnology Innovation Organization (BIO) and a member of the BIO board and its Executive
CORRESP
pkfwv 9ib2
11 Oct 22
Correspondence with SEC
12:00am
CORRESP
yy9x rw3x8hshc85
30 Sep 22
Correspondence with SEC
12:00am
6-K
EX-99.1
5gw923mslomiy610p2ah
27 May 21
U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma
12:00am
6-K
EX-99.1
li7g3k
30 Apr 21
Current report (foreign)
6:42am
20-F
04f8m6ex howw9ot
2 Apr 21
Annual report (foreign)
8:10am
6-K
EX-99.1
1l3kac7i mmeln6
1 Feb 21
Legend Biotech Corporation 6-K
7:15am
6-K
EX-99.1
2hdy9ql3
14 Dec 20
Current report (foreign)
8:10am
424B4
8aq kymcvnzamdbgsi4
8 Jun 20
Prospectus supplement with pricing info
9:07am
F-1/A
b317slycbfxbxffl1uis
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
EX-10.1
vg161hx3ds35
13 May 20
Registration statement (foreign)
4:41pm
F-1
akko7178 i4iqloc8b
13 May 20
Registration statement (foreign)
4:41pm
F-1
EX-4.4
5c77fqkhhg2
13 May 20
Registration statement (foreign)
4:41pm
DRS/A
55lavp80l3aucp05
8 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.1
0el0 j8poto
8 May 20
Draft registration statement (amended)
12:00am